IonGate, LIVC to Co-Develop, Market Ion Channel Screening Technology | GenomeWeb
NEW YORK (GenomeWeb News) - IonGate Biosciences and LIVC Technologies, both located in Frankfurt am Main, Germany, said today that they plan to co-develop and co-market LIVC’s technology for ion channel screening.
 
The technology, Light-Induced Voltage Clamp, uses light induction to measure voltage-activated ion channels. According to the companies, the method enables fast, high-throughput screening of voltage-activated ion channels and provides higher-quality data than current methods.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.